Short Interest in Nexalin Technology, Inc. (NASDAQ:NXL) Expands By 243.7%

Nexalin Technology, Inc. (NASDAQ:NXL) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 327,200 shares, an increase of 243.7% from the March 31st total of 95,200 shares. Currently, 5.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 786,600 shares, the short-interest ratio is presently 0.4 days.

Nexalin Technology Trading Up 4.0 %

NXL stock opened at $1.44 on Friday. Nexalin Technology has a twelve month low of $0.25 and a twelve month high of $3.40. The firm’s fifty day simple moving average is $1.07 and its two-hundred day simple moving average is $0.61.

About Nexalin Technology

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders.